vs
Cosmos Health Inc.（COSM）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
Cosmos Health Inc.的季度营收约是STANDARD BIOTOOLS INC.的1.0倍（$19.7M vs $19.6M），Cosmos Health Inc.净利率更高（-51.5% vs -177.4%，领先125.9%），Cosmos Health Inc.同比增速更快（38.5% vs -11.5%），Cosmos Health Inc.自由现金流更多（$-4.6M vs $-23.1M），过去两年Cosmos Health Inc.的营收复合增速更高（16.2% vs -12.2%）
阿格尼库尔宇宙私人有限公司是总部位于金奈印度理工学院燃烧研究与开发国家中心的印度民营航空航天制造商及商业发射服务提供商。这家初创企业致力于开发并发射自主小型运载火箭，其中代表性的阿格尼班火箭可将100公斤有效载荷送入700公里轨道。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
COSM vs LAB — 直观对比
营收规模更大
COSM
是对方的1.0倍
$19.6M
营收增速更快
COSM
高出50.0%
-11.5%
净利率更高
COSM
高出125.9%
-177.4%
自由现金流更多
COSM
多$18.5M
$-23.1M
两年增速更快
COSM
近两年复合增速
-12.2%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.7M | $19.6M |
| 净利润 | $-10.1M | $-34.7M |
| 毛利率 | 10.6% | 48.5% |
| 营业利润率 | -57.9% | -168.5% |
| 净利率 | -51.5% | -177.4% |
| 营收同比 | 38.5% | -11.5% |
| 净利润同比 | -203.0% | -28.8% |
| 每股收益（稀释后） | $-0.33 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收COSMLAB
| Q4 25 | $19.7M | — | ||
| Q3 25 | $17.1M | $19.6M | ||
| Q2 25 | $14.7M | $21.8M | ||
| Q1 25 | $13.7M | $40.8M | ||
| Q4 24 | $14.2M | — | ||
| Q3 24 | $12.4M | $22.1M | ||
| Q2 24 | $13.2M | $22.5M | ||
| Q1 24 | $14.6M | $45.5M |
净利润COSMLAB
| Q4 25 | $-10.1M | — | ||
| Q3 25 | $-5.4M | $-34.7M | ||
| Q2 25 | $-2.8M | $-33.5M | ||
| Q1 25 | $-818.1K | $-26.0M | ||
| Q4 24 | $-3.3M | — | ||
| Q3 24 | $-8.4M | $-26.9M | ||
| Q2 24 | $-2.6M | $-45.7M | ||
| Q1 24 | $-1.9M | $-32.2M |
毛利率COSMLAB
| Q4 25 | 10.6% | — | ||
| Q3 25 | 15.2% | 48.5% | ||
| Q2 25 | 7.9% | 48.8% | ||
| Q1 25 | 14.9% | 48.4% | ||
| Q4 24 | 7.1% | — | ||
| Q3 24 | 9.7% | 54.9% | ||
| Q2 24 | 5.8% | 46.1% | ||
| Q1 24 | 9.1% | 53.1% |
营业利润率COSMLAB
| Q4 25 | -57.9% | — | ||
| Q3 25 | -10.6% | -168.5% | ||
| Q2 25 | -17.9% | -118.1% | ||
| Q1 25 | -6.1% | -80.8% | ||
| Q4 24 | -63.0% | — | ||
| Q3 24 | -18.0% | -120.9% | ||
| Q2 24 | -18.9% | -134.5% | ||
| Q1 24 | -12.6% | -132.2% |
净利率COSMLAB
| Q4 25 | -51.5% | — | ||
| Q3 25 | -31.3% | -177.4% | ||
| Q2 25 | -19.2% | -153.7% | ||
| Q1 25 | -6.0% | -63.8% | ||
| Q4 24 | -23.5% | — | ||
| Q3 24 | -67.5% | -122.0% | ||
| Q2 24 | -19.6% | -203.3% | ||
| Q1 24 | -12.8% | -70.6% |
每股收益（稀释后）COSMLAB
| Q4 25 | $-0.33 | — | ||
| Q3 25 | $-0.17 | $-0.09 | ||
| Q2 25 | $-0.10 | $-0.09 | ||
| Q1 25 | $-0.03 | $-0.07 | ||
| Q4 24 | $-0.46 | — | ||
| Q3 24 | $-0.45 | $-0.07 | ||
| Q2 24 | $-0.15 | $-0.12 | ||
| Q1 24 | $-0.11 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $761.8K | $129.4M |
| 总债务越低越好 | $3.8M | — |
| 股东权益账面价值 | $18.4M | $399.7M |
| 总资产 | $65.5M | $539.6M |
| 负债/权益比越低杠杆越低 | 0.20× | — |
8季度趋势，按日历期对齐
现金及短期投资COSMLAB
| Q4 25 | $761.8K | — | ||
| Q3 25 | $922.6K | $129.4M | ||
| Q2 25 | $30.3K | $158.6M | ||
| Q1 25 | $25.3K | $150.9M | ||
| Q4 24 | $336.3K | — | ||
| Q3 24 | $22.8K | $210.6M | ||
| Q2 24 | $21.5K | $269.8M | ||
| Q1 24 | $21.3K | $287.1M |
总债务COSMLAB
| Q4 25 | $3.8M | — | ||
| Q3 25 | $5.4M | — | ||
| Q2 25 | $5.2M | — | ||
| Q1 25 | $4.9M | — | ||
| Q4 24 | $4.1M | — | ||
| Q3 24 | $4.3M | $55.2M | ||
| Q2 24 | $3.9M | $55.1M | ||
| Q1 24 | $4.1M | $55.0M |
股东权益COSMLAB
| Q4 25 | $18.4M | — | ||
| Q3 25 | $23.1M | $399.7M | ||
| Q2 25 | $26.2M | $424.5M | ||
| Q1 25 | $26.0M | $454.6M | ||
| Q4 24 | $24.5M | — | ||
| Q3 24 | $35.0M | $489.3M | ||
| Q2 24 | $32.1M | $510.3M | ||
| Q1 24 | $34.5M | $577.3M |
总资产COSMLAB
| Q4 25 | $65.5M | — | ||
| Q3 25 | $69.5M | $539.6M | ||
| Q2 25 | $61.8M | $557.0M | ||
| Q1 25 | $57.2M | $579.6M | ||
| Q4 24 | $54.3M | — | ||
| Q3 24 | $64.5M | $681.5M | ||
| Q2 24 | $60.8M | $708.7M | ||
| Q1 24 | $62.3M | $777.7M |
负债/权益比COSMLAB
| Q4 25 | 0.20× | — | ||
| Q3 25 | 0.23× | — | ||
| Q2 25 | 0.20× | — | ||
| Q1 25 | 0.19× | — | ||
| Q4 24 | 0.17× | — | ||
| Q3 24 | 0.12× | 0.11× | ||
| Q2 24 | 0.12× | 0.11× | ||
| Q1 24 | 0.12× | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-4.6M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $-4.6M | $-23.1M |
| 自由现金流率自由现金流/营收 | -23.4% | -118.1% |
| 资本支出强度资本支出/营收 | 0.0% | 4.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-8.5M | $-111.1M |
8季度趋势，按日历期对齐
经营现金流COSMLAB
| Q4 25 | $-4.6M | — | ||
| Q3 25 | $-2.5M | $-22.2M | ||
| Q2 25 | $-1.2M | $-20.7M | ||
| Q1 25 | $-186.3K | $-30.3M | ||
| Q4 24 | $-3.8M | — | ||
| Q3 24 | $739.8K | $-27.9M | ||
| Q2 24 | $-1.2M | $-39.0M | ||
| Q1 24 | $-3.4M | $-62.5M |
自由现金流COSMLAB
| Q4 25 | $-4.6M | — | ||
| Q3 25 | $-2.5M | $-23.1M | ||
| Q2 25 | $-1.2M | $-22.6M | ||
| Q1 25 | $-198.8K | $-35.3M | ||
| Q4 24 | $-3.9M | — | ||
| Q3 24 | $511.0K | $-30.1M | ||
| Q2 24 | $-1.2M | $-41.0M | ||
| Q1 24 | $-3.5M | $-63.3M |
自由现金流率COSMLAB
| Q4 25 | -23.4% | — | ||
| Q3 25 | -14.4% | -118.1% | ||
| Q2 25 | -8.4% | -103.6% | ||
| Q1 25 | -1.5% | -86.6% | ||
| Q4 24 | -27.5% | — | ||
| Q3 24 | 4.1% | -136.4% | ||
| Q2 24 | -9.4% | -182.2% | ||
| Q1 24 | -24.0% | -138.9% |
资本支出强度COSMLAB
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.1% | 4.5% | ||
| Q2 25 | 0.2% | 8.7% | ||
| Q1 25 | 0.1% | 12.4% | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 1.8% | 10.2% | ||
| Q2 24 | 0.3% | 8.6% | ||
| Q1 24 | 0.6% | 1.7% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
COSM
暂无分部数据
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
